Literature DB >> 27581990

Sindbis Virus Can Exploit a Host Antiviral Protein To Evade Immune Surveillance.

Xinlu Wang1, Melody M H Li2, Jing Zhao3, Shenglan Li1, Margaret R MacDonald2, Charles M Rice2, Xiang Gao3, Guangxia Gao4.   

Abstract

Viral infection induces production of type I interferons (IFNs), which stimulate the expression of a variety of antiviral factors to inhibit viral replication. To establish effective infection, viruses need to develop strategies to evade the immune responses. A neurovirulent Sindbis virus strain with neuroinvasive properties (SVNI) causes lethal encephalitis in mice, and its replication in cultured cells is inhibited by the zinc finger antiviral protein (ZAP), a host factor that specifically inhibits the replication of certain viruses by binding to the viral mRNAs, repressing the translation of target mRNA, and promoting the degradation of target mRNA. We report here that murine embryonic fibroblast cells from ZAP knockout mice supported more efficient SVNI replication than wild-type cells. SVNI infection of 10-day-old suckling mice led to reduced survival in the knockout mice. Unexpectedly, however, SVNI infection of 23-day-old weanling mice, whose immune system is more developed than that of the suckling mice, resulted in significantly improved survival in ZAP knockout mice. Further analyses revealed that in the weanling knockout mice, SVNI replicated more efficiently in lymphoid tissues at early times postinfection and induced higher levels of IFN production, which restricted viral spread to the central nervous system. Blocking IFN activity through the use of receptor-neutralizing antibodies rendered knockout mice more sensitive to SVNI infection than wild-type mice. These results uncover a mechanism by which SVNI exploits a host antiviral factor to evade innate immune surveillance. IMPORTANCE: Sindbis virus, a prototypic member of the Alphavirus genus, has been used to study the pathogenesis of acute viral encephalitis in mice for many years. How the virus evades immune surveillance to establish effective infection is largely unknown. ZAP is a host antiviral factor that potently inhibits Sindbis virus replication in cell culture. We show here that infection of ZAP knockout suckling mice with an SVNI led to faster disease progression. However, SVNI infection of weanling mice led to slower disease progression in knockout mice. Further analyses revealed that in weanling knockout mice, SVNI replicated more efficiently in lymphoid tissues at early times postinfection and induced higher levels of interferon production, which restricted viral spread to the central nervous system. These results uncover a mechanism by which SVNI exploits a host antiviral factor to evade innate immune surveillance and allow enhanced neuroinvasion.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27581990      PMCID: PMC5105660          DOI: 10.1128/JVI.01487-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

Review 1.  Type I interferons in host defense.

Authors:  Daniel B Stetson; Ruslan Medzhitov
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

2.  Identification of the inflammatory cells present in the central nervous system of normal and mast cell-deficient mice during Sindbis virus encephalitis.

Authors:  D E Griffin; Q P Mendoza
Journal:  Cell Immunol       Date:  1986-02       Impact factor: 4.868

3.  Inhibition of filovirus replication by the zinc finger antiviral protein.

Authors:  Stefanie Müller; Peggy Möller; Matthew J Bick; Stephanie Wurr; Stephan Becker; Stephan Günther; Beate M Kümmerer
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

4.  Infection of neonatal mice with sindbis virus results in a systemic inflammatory response syndrome.

Authors:  W B Klimstra; K D Ryman; K A Bernard; K B Nguyen; C A Biron; R E Johnston
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells.

Authors:  Gil Ju Seo; Rodney P Kincaid; Teva Phanaksri; James M Burke; Justin M Pare; Jennifer E Cox; Tien-Ying Hsiang; Robert M Krug; Christopher S Sullivan
Journal:  Cell Host Microbe       Date:  2013-09-26       Impact factor: 21.023

Review 6.  CD69 and regulation of the immune function.

Authors:  R Marzio; J Mauël; S Betz-Corradin
Journal:  Immunopharmacol Immunotoxicol       Date:  1999-08       Impact factor: 2.730

7.  Expression of the zinc-finger antiviral protein inhibits alphavirus replication.

Authors:  Matthew J Bick; John-William N Carroll; Guangxia Gao; Stephen P Goff; Charles M Rice; Margaret R MacDonald
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

8.  ZAP-mediated mRNA degradation.

Authors:  Yiping Zhu; Guangxia Gao
Journal:  RNA Biol       Date:  2008-04-03       Impact factor: 4.652

9.  Both RIG-I and MDA5 detect alphavirus replication in concentration-dependent mode.

Authors:  Ivan Akhrymuk; Ilya Frolov; Elena I Frolova
Journal:  Virology       Date:  2015-11-06       Impact factor: 3.616

10.  RNA viruses can hijack vertebrate microRNAs to suppress innate immunity.

Authors:  Derek W Trobaugh; Christina L Gardner; Chengqun Sun; Andrew D Haddow; Eryu Wang; Elik Chapnik; Alexander Mildner; Scott C Weaver; Kate D Ryman; William B Klimstra
Journal:  Nature       Date:  2013-12-18       Impact factor: 49.962

View more
  10 in total

1.  The Short Form of the Zinc Finger Antiviral Protein Inhibits Influenza A Virus Protein Expression and Is Antagonized by the Virus-Encoded NS1.

Authors:  Qiannan Tang; Xinlu Wang; Guangxia Gao
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

2.  RNA-binding protein isoforms ZAP-S and ZAP-L have distinct antiviral and immune resolution functions.

Authors:  Johannes Schwerk; Frank W Soveg; Andrew P Ryan; Kerri R Thomas; Lauren D Hatfield; Snehal Ozarkar; Adriana Forero; Alison M Kell; Justin A Roby; Lomon So; Jennifer L Hyde; Michael Gale; Matthew D Daugherty; Ram Savan
Journal:  Nat Immunol       Date:  2019-11-18       Impact factor: 25.606

3.  ZAP's stress granule localization is correlated with its antiviral activity and induced by virus replication.

Authors:  Lok Man John Law; Brandon S Razooky; Melody M H Li; Shihyun You; Andrea Jurado; Charles M Rice; Margaret R MacDonald
Journal:  PLoS Pathog       Date:  2019-05-22       Impact factor: 6.823

Review 4.  Genetic control of alphavirus pathogenesis.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Mamm Genome       Date:  2018-08-27       Impact factor: 2.957

5.  The role of ZAP and OAS3/RNAseL pathways in the attenuation of an RNA virus with elevated frequencies of CpG and UpA dinucleotides.

Authors:  Valerie Odon; Jelke J Fros; Niluka Goonawardane; Isabelle Dietrich; Ahmad Ibrahim; Kinda Alshaikhahmed; Dung Nguyen; Peter Simmonds
Journal:  Nucleic Acids Res       Date:  2019-09-05       Impact factor: 19.160

Review 6.  The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions.

Authors:  Anthony R Fehr; Sasha A Singh; Catherine M Kerr; Shin Mukai; Hideyuki Higashi; Masanori Aikawa
Journal:  Genes Dev       Date:  2020-02-06       Impact factor: 11.361

Review 7.  Mammalian and Avian Host Cell Influenza A Restriction Factors.

Authors:  Joe McKellar; Antoine Rebendenne; Mélanie Wencker; Olivier Moncorgé; Caroline Goujon
Journal:  Viruses       Date:  2021-03-22       Impact factor: 5.048

8.  TMEM106A inhibits enveloped virus release from cell surface.

Authors:  Dexin Mao; Feixiang Yan; Xiaolin Zhang; Guangxia Gao
Journal:  iScience       Date:  2022-02-01

Review 9.  Innate immune evasion by alphaviruses.

Authors:  Yihan Liu; Yupei Yuan; Leiliang Zhang
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

Review 10.  De-Coding the Contributions of the Viral RNAs to Alphaviral Pathogenesis.

Authors:  Autumn T LaPointe; Kevin J Sokoloski
Journal:  Pathogens       Date:  2021-06-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.